● Once patents expire for biologic medicines, a market opportunity opens up for biosimilars, a cheaper alternative. Biosimilars were mainly brought in to thwart the monopoly power of biologics in the pharmaceutical industry. ● Biosimilars are expected to increase at...

According to a report by the US Food and Drug Administration (FDA), increased generic drug entry will lead to price reductions in the market (see our table below) as well as huge savings opportunities for patients, or at least...

Malone Mukwende, a medical student from St. George's, University of London noticed during his studies that there was a problem with Ethnic Dermatology. Mr Mukwende's observation leads us to wider questions over healthcare investment opportunities, telemedicine, remote patient monitoring,...

● The UK government's PPE contracts surged, as of the beginning of July, and were, at least in part, awarded to smaller companies (see exhibit below). It is about more than just the cash, however welcome that it...

Researchers at Vanderbilt University Medical Centre (VUMC), based in Amsterdam, have recently published optimistic results from monoclonal antibody preclinical trials in Nature Medicine that could potentially be a breakthrough in the search for both a curative for the Covid-19...

A framework allowing a more sensible approach to health data collection In our previous blog we outlined the pressure on hospital margins and the entire hospital business model as a direct result of Covid-19. One solution is the sale by...

AZN's market-cap breached the £100bn break-out line thanks to the Covid-crisis, the British pharma giant promised that during the pandemic it won’t make profit on the vaccine, but maybe it should.         AZN.L relative 12m share price performance (lighter line) vs....

Covid-19 has given us a glimpse into the long and costly process of drug development. While health experts are speculating on a covid-19 vaccine by 2021, the reality is that the drug development process can take about 10-15 years...

At the moment there isn't any underlying evidence as to whether or not a face mask could kill the Covid-19 virus using electricity as indicated in the story on 5th June 2020 in Popular Mechanics (which we summarise below),...

The Food and Drug Administration (FDA - US healthcare regulator) will endeavour to review many drugs applications in the next year in relation to coronavirus, but concerns are emerging that if the FDA follows its old ways it will...